Abingdon Health PLC (ABDX) Price & Analysis

Compare

22 Followers

ABDX Stock Chart & Stats

6.25 p

0.20 p(2.50%)

At close: Jan 09 4:00 PM EST

6.25 p

0.20 p(2.50%)

Day’s Range― - ―

52-Week Range5.10 p - 9.00 p

Previous CloseN/A

Volume7.61K

Average Volume (3M)78.74K

Market Cap

£20.71M

Enterprise Value15.08M

Total Cash (Recent Filing)£1.92M

Total Debt (Recent Filing)£1.03M

Price to Earnings (P/E)―

Beta-0.17

Next Earnings

Mar 17, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding251,077,850

10 Day Avg. Volume45,332

30 Day Avg. Volume78,736

Financial Highlights & Ratios

PEG Ratio-0.06

Price to Book (P/B)4.84

Price to Sales (P/S)3.04

P/FCF Ratio-7.48

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)>-0.01

Revenue Forecast (FY)£12.20M

Bulls Say, Bears Say

Bulls Say

Revenue Growth TrendSustained revenue growth near mid-20% indicates expanding market adoption of the company's rapid diagnostic tests. Durable top-line momentum supports scale benefits, capacity utilization and incremental investment in R&D or sales channels, strengthening long-term commercial traction.

Diversified Revenue ModelA multi-channel revenue model—product sales, co-development partnerships and licensing—reduces single-customer risk and enables recurring and contract-driven income. Structural diversity supports resilience across cycles and provides multiple routes to scale and margin improvement over time.

Manageable LeverageLow leverage provides financial flexibility to fund growth, R&D and working capital without excessive fixed financing costs. This structural strength lowers bankruptcy risk and preserves capacity to raise capital on reasonable terms if needed for strategic investments or to cover cash shortfalls.

Bears Say

Profitability PressurePersistent negative margins signal structural cost or pricing issues that limit the firm's ability to convert revenue into sustainable profits. Over the medium term this hampers reinvestment, reduces retained earnings available for growth, and pressures management to improve operating efficiency.

Negative Operating Cash FlowNegative operating cash flow despite revenue growth indicates weak cash conversion and reliance on external financing. Structurally, this constrains the company's ability to fund working capital and capex internally, increasing vulnerability to funding cost rises or tighter capital markets.

Weak Returns / EPS DeclineA steep EPS decline and negative ROE reflect inability to generate shareholder returns from invested capital. This undermines long-term capital efficiency, suggests operational or margin weaknesses, and can limit access to attractive financing or strategic partner opportunities.

Abingdon Health PLC News

Abingdon Health Wins $2.5m Clinical Self-Test Contract, Bolstering Diagnostics Role

An update from Abingdon Health PLC ( ($GB:ABDX) ) is now available. Abingdon Health plc, a U.K.-based med-tech...

4d ago

Abingdon Health Targets US Investors With OTCQB Listing After Wisconsin Expansion

Abingdon Health PLC ( ($GB:ABDX) ) has issued an announcement. Abingdon Health is deepening its US presence by...

6d ago

Abingdon Health Sets Date for Interim Results and Investor Presentation

Abingdon Health PLC ( ($GB:ABDX) ) has shared an update. Abingdon Health plc, an AIM-quoted international developer, manufacturer...

11d ago

Abingdon Health lifts H1 revenues 45% and backs full-year guidance amid US expansion

Abingdon Health PLC ( ($GB:ABDX) ) has shared an update. Abingdon Health reported a 45% rise in first-half...

2M ago

Abingdon Health Names Cavendish as Sole Broker and Nominated Adviser

Abingdon Health PLC ( ($GB:ABDX) ) has provided an update. Abingdon Health plc, a specialist in rapid diagnostic...

2M ago

Abingdon Health Updates Share Capital Following Option Exercise

Abingdon Health PLC ( ($GB:ABDX) ) has issued an announcement. Abingdon Health plc, an international developer and manufacturer...

3M ago

Abingdon Health Secures European Patent for Innovative Smartphone-Based Diagnostics

Abingdon Health PLC ( ($GB:ABDX) ) has shared an announcement. Abingdon Health PLC has secured a European patent...

3M ago

Abingdon Health PLC Secures Strong Shareholder Support at AGM

An update from Abingdon Health PLC ( ($GB:ABDX) ) is now available. Abingdon Health PLC announced that all...

3M ago

Abingdon Health Updates LTIP with New Share Awards

Abingdon Health PLC ( ($GB:ABDX) ) just unveiled an announcement. Abingdon Health PLC announced updates to its Long...

3M ago

Abingdon Health PLC Announces AGM Date and Publishes 2025 Annual Report

Abingdon Health PLC ( ($GB:ABDX) ) just unveiled an announcement. Abingdon Health PLC has announced the date for...

4M ago

ABDX FAQ

What was Abingdon Health PLC’s price range in the past 12 months?

Abingdon Health PLC lowest share price was 5.10 p and its highest was 9.00 p in the past 12 months.

What is Abingdon Health PLC’s market cap?

Abingdon Health PLC’s market cap is £20.71M.

When is Abingdon Health PLC’s upcoming earnings report date?

Abingdon Health PLC’s upcoming earnings report date is Mar 17, 2026 which is tomorrow.

How were Abingdon Health PLC’s earnings last quarter?

Abingdon Health PLC released its earnings results on Nov 11, 2025. The company reported -0.002 p earnings per share for the quarter, missing the consensus estimate of N/A by -0.002 p.

Is Abingdon Health PLC overvalued?

According to Wall Street analysts Abingdon Health PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Abingdon Health PLC pay dividends?

Abingdon Health PLC does not currently pay dividends.

What is Abingdon Health PLC’s EPS estimate?

Abingdon Health PLC’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Abingdon Health PLC have?

Abingdon Health PLC has 251,077,850 shares outstanding.

What happened to Abingdon Health PLC’s price movement after its last earnings report?

Abingdon Health PLC reported an EPS of -0.002 p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -7.143%.

Which hedge fund is a major shareholder of Abingdon Health PLC?

Currently, no hedge funds are holding shares in GB:ABDX

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Abingdon Health PLC

Abingdon Health PLC (ABDX) is a UK-based company specializing in the development and manufacture of rapid diagnostic tests. The company focuses on providing innovative solutions in the healthcare sector, particularly in the fields of infectious diseases, including COVID-19 testing, and other point-of-care testing applications. Abingdon Health aims to enhance patient outcomes through its high-quality, reliable diagnostics that are designed for use in various settings, ranging from hospitals to home testing.